Cardiovascular Disease Clinical Trial
— SAWYESOfficial title:
Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study
The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | August 2015 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 40 Years to 65 Years |
Eligibility |
Inclusion Criteria: - 40- 65 years old - Postmenopausal (amenorrhea for = 12 months) - Overweight as evidenced by a body mass index (BMI) = 25 kg/m2), or waist circumference = 80 cm, or have a first degree relative with diabetes or essential hypertension - Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week) - Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere - Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group. Exclusion Criteria: - Have had a period within the last year - Are not between the ages of 40 and 65 - Have experience with yoga within the last 12 months - Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma) - Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke - Have a severe infectious or other medical illness right now such as pneumonia - Use medications to lower blood sugar levels - Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program - Regularly use an assistive device (e.g., cane, walker) to walk |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Canada | Kwantlen Polytechnic University | Surrey | British Columbia |
Canada | The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic | Surrey | British Columbia |
Lead Sponsor | Collaborator |
---|---|
Kwantlen Polytechnic University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in blood pressure | blood pressure is measured as a specific physiologic index of cardiovascular risk. | baseline, at end of study (12 wks), & 3 months post-study | No |
Secondary | Change in subjective well-being | The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being. | baseline, at end of study (12 wks), & 3 months post-study | No |
Secondary | Change in perceived physical well-being | Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in insulin sensitivity | Fasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in inflammation | C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in serum total cholesterol | Serum total cholesterol will be measured as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in serum high-density lipoprotein (HDL) cholesterol | Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in serum low-density lipoprotein (LDL) cholesterol | Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in serum triglycerides | Serum triglycerides will be measured as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in waist circumference. | Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change waist-hip ratio | Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in body mass index (BMI) | Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in resting heart rate | Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk | baseline, end of study (12 wks) & 3 months post-study | No |
Secondary | Change in heart rate | Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk | baseline, at end of study (12 wks), & 3 months post-study | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|